DYT1 dystonia is an inherited disease linked to mutation in the TOR1A gene encoding for the protein torsinA. Although the mechanism by which this genetic alteration leads to dystonia is unclear, multiple lines of clinical evidence suggest a link between dystonia and a reduced dopamine D2 receptor (D2R) availability. Based on this evidence, herein we carried out a comprehensive analysis of electrophysiological, behavioral and signaling correlates of D2R transmission in transgenic mice with the DYT1 dystonia mutation. Electrophysiological recordings from nigral dopaminergic neurons showed a normal responsiveness to D2-autoreceptor function. Conversely, postsynaptic D2R function in hMT mice was impaired, as suggested by the inability of a D2R agonist to re-establish normal corticostriatal synaptic plasticity and supported by the reduced sensitivity to haloperidol-induced catalepsy. Although an in situ hybridization analysis showed normal D1R and D2R mRNA expression levels in the striata of hMT mice, we found a significant decrease of D2R protein, coupled to a reduced ability of D2Rs to activate their cognate Go/i proteins. Of relevance, we found that pharmacological blockade of adenosine A2A receptors (A2ARs) fully restored the impairment of synaptic plasticity observed in hMT mice. Together, our findings demonstrate an important link between torsinA mutation and D2R dysfunction and suggest that A2AR antagonism is able to counteract the deficit in D2R-mediated transmission observed in mutant mice, opening new perspectives for the treatment of this movement disorder.
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Introduction
Most cases of early-onset generalized torsion dystonia (DYT1) dystonia are caused by a GAG deletion in the TOR1A gene, coding for the protein torsinA (Ozelius et al., 1997). On a cellular level, the function of torsinA is still poorly understood, although it appears to perform chaperone-like functions and participate in membrane protein trafficking, vesicle fusion and secretory processing (for rev. see Breakefield et al., 2008; Tanabe et al., 2009 ). Neuropathological studies in DYT1 dystonia have been limited, and no explicit evidence for neurodegeneration has been reported, suggesting that the DYT1 mutation produces dystonia through neurochemical abnormalities within the basal ganglia, and more specifically within the striatum (Todd and Perlmutter 1998; Rostasy et al., 2003 , Breakefield et al., 2008 . In such a context, dopamine (DA) is the neurotransmitter most clearly linked to human dystonia (Augood et al., 2002 (Augood et al., , 2004 Perlmutter and Mink, 2004) . Several imaging studies have identified DA D2 receptor (D2R) alterations in patients with primary dystonia (Perlmutter et al., 1997; Furukawa et al., 2000; Asanuma et al., 2005) . Notably, recent PET studies demonstrate a significant reduction of D2R availability in the caudate/putamen of both manifesting and nonmanifesting DYT1 mutation carriers (Carbon et al., 2009) , suggesting that these alterations might represent a dystonic endophenotype of the disease. 
